New research indicates that patients who discontinue popular slimming jabs like semaglutide or tirzepatide can put back on reduced body mass at a significantly accelerated pace than those who halt conventional diet and exercise programs.
Published data in a prominent health publication demonstrates that while obese individuals frequently drop substantial amounts of their total mass while using the jabs, the mass returns at an estimated rate of nearly a kilo each month once they quit.
"People buying these medications need to be cognizant of the danger of rapid weight regain when the therapy is stopped," cautioned researcher Dr. Susan Jebb.
That rate of regain suggests a reversion to pre-treatment mass within about 18 months.
Comparing Therapies
The analysis, which examined dozens of trials involving thousands of participants, contrasted the results of these new drugs with other pills.
The team point out that individuals who shed pounds through dieting typically see a less rapid creep back—perhaps 0.1 kg a month—once they finish.
The Reason for the Fast Rebound
Experts propose the way of the jabs is key to understanding the amplified rebound.
The injections mimic a body's own chemical called GLP-1, which controls hunger.
"Artificially providing the hormone levels several times higher than normal could lead to the body to generate a reduced amount of its endogenous GLP-1, and may also lessen responsiveness to its effects," noted Dr. Adam Collins, a nutrition expert.
"Discontinuation of this hormone supplement leads to hunger is unsuppressed, making excessive eating far more likely."
A Lifelong Disease?
Medical guidelines advise the jabs for people with weight-linked medical conditions, alongside prescribed diet and exercise modifications.
A number of clinicians say that, due to the likelihood of relapse, the therapy might need to be ongoing.
This opinion is echoed by pharmaceutical companies, who note that the findings "underscore the long-term nature of excess weight," comparing it to managing conditions like high blood pressure.
User Accounts
Individuals who have discontinued the jabs describe a intense return of appetite.
"It was like something activating and I was suddenly extremely hungry," described an individual.
The struggle is worsened if individuals have not developed sustainable lifestyle or habit changes during therapy.
Widespread Use
Recent estimates indicate that millions of people in the UK have used weight-loss jabs in the past year, with interest remaining high.
- Adoption is greater among females than men.
- The 40s and 50s demographic shows the greatest level of interest.
- Many obtain the drugs through private prescriptions rather than the NHS.
Ultimately, researchers emphasize that while the jabs are powerful agents for weight loss, they are not a standalone cure and maintained weight loss relies on integrated behavioural management.
